AVEO logo

AVEO Pharmaceuticals (AVEO) Return On Equity

Annual ROE

-131.44%
+10.50%+7.40%

December 31, 2021

Summary

Performance

1-Year Change

+7.4%

3-Year Change

-771.64%

5-Year Change

-182.4%

15-Year Change

-182.4%

AVEO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

159.52%
AVEO annual return on equity is currently -182.40% below its historical high of 159.52%

3-Year Low

-131.44%
AVEO annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
AVEO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
AVEO next annual earnings announcement has not yet been scheduled

OtherAVEOprofitabilitymetrics:

Annual Revenue

$42.30 M
AVEO annual revenue is $42.30 million

Annual Net Income

-$53.34 M
AVEO annual net profit is -$53.34 million

Annual EPS

-$1.63
AVEO annual earnings per share is -$1.63

Annual ROA

-61.93%
AVEO annual return on assets is -61.93%

Quarterly ROE

-75.04%
+5.33%+6.63%

September 30, 2022

Summary

Performance

3-Month Change

+6.63%

1-Year Change

+32.4%

3-Year Change

+86.63%

5-Year Change

-115.42%

AVEO Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

1645.91%
AVEO quarterly return on equity is currently -104.56% below its historical high of 1645.91%

3-Year Low

-100.63%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
AVEO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
AVEO next earnings announcement has not yet been scheduled

OtherAVEOprofitabilitymetrics:

Quarterly Revenue

$30.45 M
AVEO quarterly revenue is $30.45 million

Quarterly Net Income

-$3.27 M
AVEO quarterly net profit is -$3.27 million

Quarterly EPS

-$0.09
AVEO quarterly earnings per share is -$0.09

Quarterly ROA

-28.36%
AVEO quarterly return on assets is -28.36%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

-131.44%
AVEO annual return on equity is -131.44%

Annual Net Income

-$53.34 M
AVEO annual net profit is -$53.34 million

Annual Shareholders Equity

$45.87 M
AVEO annual stockholders equity is $45.87 million

AVEO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.4%+32.4%
3 y3 years-771.6%+86.6%
5 y5 years-182.4%-115.4%

AVEO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat lowat high+34.1%
5 y5-year-307.8%+8.0%-133.3%+63.0%
alltimeall time-182.4%+167.3%-104.6%+3152.1%

AVEO Pharmaceuticals ROE History

DateAnnualQuarterly
Sep 2022
-
-75.04%(-6.6%)
Jun 2022
-
-80.37%(+3.5%)
Mar 2022
-
-77.65%(-22.8%)
Dec 2021
-131.44%(-7.4%)
-100.63%(-9.4%)
Sep 2021
-
-111.01%(+2.3%)
Jun 2021
-
-108.53%(-10.7%)
Mar 2021
-
-121.48%(-0.7%)
Dec 2020
-141.94%(-324.4%)
-122.35%(+10.5%)
Sep 2020
-
-110.72%(+437.7%)
Jun 2020
-
-20.59%(-315.6%)
Mar 2020
-
9.55%(-95.8%)
Dec 2019
63.24%(+223.1%)
225.40%(-140.1%)
Sep 2019
-
-561.40%(-5117.0%)
Jun 2019
-
11.19%(-200.6%)
Mar 2019
-
-11.12%(-195.6%)
Dec 2018
19.57%(-87.7%)
11.63%(-75.8%)
Sep 2018
-
48.05%(-22.0%)
Jun 2018
-
61.61%(-63.4%)
Mar 2018
-
168.28%(-35.5%)
Dec 2017
159.52%(-145.4%)
260.74%(-46.4%)
Sep 2017
-
486.76%(-70.4%)
Jun 2017
-
1645.91%(-390.6%)
Mar 2017
-
-566.48%(+56.1%)
Dec 2016
-351.37%(+343.1%)
-362.90%(+63.7%)
Sep 2016
-
-221.74%(+108.7%)
Jun 2016
-
-106.25%(+37.9%)
Mar 2016
-
-77.04%(-10.1%)
Dec 2015
-79.30%
-85.70%(-19.7%)
DateAnnualQuarterly
Sep 2015
-
-106.66%(-39.0%)
Jun 2015
-
-174.91%(+10.6%)
Mar 2015
-
-158.18%(+41.6%)
Dec 2014
-116.49%(+2.8%)
-111.72%(+21.1%)
Sep 2014
-
-92.23%(+6.0%)
Jun 2014
-
-87.05%(+3.1%)
Mar 2014
-
-84.44%(-17.2%)
Dec 2013
-113.33%(+69.7%)
-101.98%(+8.2%)
Sep 2013
-
-94.25%(+7.9%)
Jun 2013
-
-87.36%(+14.8%)
Mar 2013
-
-76.11%(+11.7%)
Dec 2012
-66.80%(-421.8%)
-68.14%(+11.6%)
Sep 2012
-
-61.07%(+19.8%)
Jun 2012
-
-50.97%(+26.3%)
Mar 2012
-
-40.37%(-355.2%)
Dec 2011
20.76%(-125.3%)
15.82%(-46.6%)
Sep 2011
-
29.61%(-34.3%)
Jun 2011
-
45.05%(-24.9%)
Mar 2011
-
60.02%(-102.5%)
Dec 2010
-81.91%(-416.4%)
-2440.39%(-715.6%)
Sep 2010
-
396.42%(+343.8%)
Jun 2010
-
89.33%(+72.3%)
Mar 2010
-
51.84%(+94.1%)
Dec 2009
25.89%(+2.6%)
26.71%(-8.2%)
Sep 2009
-
29.10%(+32.5%)
Jun 2009
-
21.96%(+56.7%)
Mar 2009
-
14.01%(+109.1%)
Dec 2008
25.23%(-0.6%)
6.70%
Dec 2007
25.37%
-

FAQ

  • What is AVEO Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals annual ROE year-on-year change?
  • What is AVEO Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for AVEO Pharmaceuticals?
  • What is AVEO Pharmaceuticals quarterly ROE year-on-year change?

What is AVEO Pharmaceuticals annual return on equity?

The current annual ROE of AVEO is -131.44%

What is the all time high annual ROE for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high annual return on equity is 159.52%

What is AVEO Pharmaceuticals annual ROE year-on-year change?

Over the past year, AVEO annual return on equity has changed by +10.50% (+7.40%)

What is AVEO Pharmaceuticals quarterly return on equity?

The current quarterly ROE of AVEO is -75.04%

What is the all time high quarterly ROE for AVEO Pharmaceuticals?

AVEO Pharmaceuticals all-time high quarterly return on equity is 1645.91%

What is AVEO Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, AVEO quarterly return on equity has changed by +35.97% (+32.40%)